GlaxoSmithKline Pharmaceuticals Limited — Others, 24-12-2024: Trading Window

GlaxoSmithKline Pharmaceuticals Limited has announced a board meeting on 10th February 2025 to approve and declare the financial results for the quarter and half-year ending 31st December 2024. In accordance with SEBI regulations, the trading window will be closed from 1st January 2025 until it reopens on 13th February 2025. This closure is standard practice ahead of the financial results, which could heighten volatility in share performance. Investors may view this as a neutral impact, pending the upcoming results, while remaining aware of potential market reactions following the announcements.